Glial-scar-free chronic neural implant materials
Electrode and substrate materials compliant and inert enough that implanted devices record and stimulate the same neurons for decades without encapsulation or neuron loss.
State of the art
Syringe-injectable mesh electronics with near-absent glial response in mice; human Utah-array recordings degrade in unit yield over years.
- Micromotion between rigid device and pulsating tissue drives chronic inflammation
- Thin-film encapsulation (polyimide, parylene, SiC) eventually admits water and fails
- Electrode charge-injection limits and corrosion under years of continuous stimulation
Who’s working on it
- Jia Liu ↗ResearcherHarvard SEAS
Pioneer of tissue-like and syringe-injectable mesh electronics; co-founded Axoft
- AxoftStartup
Soft Fleuron polymer probe completed a first-in-human safety study in 2025; raised over $18M
- Paradromics ↗Startup
Reported four years of stable preclinical recording in 2026 with platinum-iridium microwires and a titanium hermetic package
- Neuralink ↗Startup
Thin polymer thread electrodes implanted in multiple human participants since 2024
- Precision Neuroscience ↗Startup
Thin-film surface arrays implanted in 50+ patients; received FDA clearance for up to 30-day implantation in 2025
- NIH BRAIN InitiativeProgram
Funds neural-interface materials and long-term stability research; ~$3.5B invested since 2014
What to invest in
| Kind | Investment | Scale |
|---|---|---|
| research | Hermetic, tissue-compliant encapsulation validated by accelerated-aging plus multi-year large-animal implants with quantified unit yield | $$ $10M – $100M |
| engineering | Wafer-scale manufacture of flexible 10k-channel arrays with yield and sterilization qualification | $$$ $100M – $1B |
Depends on
A root node: no prerequisites modeled.